M Kato-Maeda1, E Y Kim, L Flores, L G Jarlsberg, D Osmond, P C Hopewell. 1. Francis J Curry National Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, California 94110, USA. midori.kato-maeda@ucsf.edu
Abstract
SETTING: The East-Asian lineage of Mycobacterium tuberculosis is composed of five sublineages, and includes the strains from the Beijing spoligotype family. In some studies these strains were highly pathogenic, although other studies did not support this finding. OBJECTIVE: To determine if the sublineages of the East-Asian lineage of M. tuberculosis differ in their capacity to cause secondary cases, as assessed by genotypic clustering of isolates. DESIGN: In a population-based study of 545 patients with M. tuberculosis from the East-Asian lineage in San Francisco, we used DNA-based fingerprinting to identify genotypic clustering, which was compared among the different sublineages defined by large sequence polymorphism. RESULTS: Strains from sublineage 207 had the highest frequency of genotypic clustering. In the multivariate analysis, only patients born in the United States were associated with clustering. CONCLUSIONS: We found evidence in a univariate analysis that the different East-Asian sublineages of M. tuberculosis have different frequencies of genotypic clustering. The effect size for this difference was unchanged in multivariate analysis, although loss of observations due to missing data resulted in a non-significant P value. It is tantalizing to hypothesize that the different East-Asian sublineages may differ in their capacity to cause secondary cases.
SETTING: The East-Asian lineage of Mycobacterium tuberculosis is composed of five sublineages, and includes the strains from the Beijing spoligotype family. In some studies these strains were highly pathogenic, although other studies did not support this finding. OBJECTIVE: To determine if the sublineages of the East-Asian lineage of M. tuberculosis differ in their capacity to cause secondary cases, as assessed by genotypic clustering of isolates. DESIGN: In a population-based study of 545 patients with M. tuberculosis from the East-Asian lineage in San Francisco, we used DNA-based fingerprinting to identify genotypic clustering, which was compared among the different sublineages defined by large sequence polymorphism. RESULTS: Strains from sublineage 207 had the highest frequency of genotypic clustering. In the multivariate analysis, only patients born in the United States were associated with clustering. CONCLUSIONS: We found evidence in a univariate analysis that the different East-Asian sublineages of M. tuberculosis have different frequencies of genotypic clustering. The effect size for this difference was unchanged in multivariate analysis, although loss of observations due to missing data resulted in a non-significant P value. It is tantalizing to hypothesize that the different East-Asian sublineages may differ in their capacity to cause secondary cases.
Authors: J T Rhee; M M Tanaka; M A Behr; C B Agasino; E A Paz; P C Hopewell; P M Small Journal: Int J Tuberc Lung Dis Date: 2000-12 Impact factor: 2.373
Authors: Viviana Ritacco; Beatriz López; Patricia I Cafrune; Lucilaine Ferrazoli; Philip N Suffys; Norma Candia; Lucy Vásquez; Teresa Realpe; Jorge Fernández; Karla V Lima; Jeannete Zurita; Jaime Robledo; Maria L Rossetti; Afranio L Kritski; Maria A Telles; Juan C Palomino; Herre Heersma; Dick van Soolingen; Kristin Kremer; Lucía Barrera Journal: Mem Inst Oswaldo Cruz Date: 2008-08 Impact factor: 2.743
Authors: Kristin Kremer; Marieke J van-der-Werf; Betty K Y Au; Dang D Anh; Kai M Kam; H Rogier van-Doorn; Martien W Borgdorff; Dick van-Soolingen Journal: Emerg Infect Dis Date: 2009-02 Impact factor: 6.883
Authors: Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen Journal: Emerg Infect Dis Date: 2002-08 Impact factor: 6.883
Authors: Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts Journal: Antimicrob Agents Chemother Date: 2011-12-05 Impact factor: 5.191
Authors: Simone C M Ribeiro; Lia Lima Gomes; Eduardo P Amaral; Marcelle R M Andrade; Fabricio M Almeida; Andreza L Rezende; Verônica R Lanes; Eulógio C Q Carvalho; Philip N Suffys; Igor Mokrousov; Elena B Lasunskaia Journal: J Clin Microbiol Date: 2014-05-14 Impact factor: 5.948
Authors: Brian Temple; Awewura Kwara; Imran Sunesara; Leandro Mena; Thomas Dobbs; Harold Henderson; Mike Holcomb; Risa Webb Journal: South Med J Date: 2011-12 Impact factor: 0.954
Authors: Midori Kato-Maeda; Crystal A Shanley; David Ackart; Leah G Jarlsberg; Shaobin Shang; Andres Obregon-Henao; Marisabel Harton; Randall J Basaraba; Marcela Henao-Tamayo; Joyce C Barrozo; Jordan Rose; L Masae Kawamura; Mireia Coscolla; Viacheslav Y Fofanov; Heather Koshinsky; Sebastien Gagneux; Philip C Hopewell; Diane J Ordway; Ian M Orme Journal: Clin Vaccine Immunol Date: 2012-06-20
Authors: Hanna Nebenzahl-Guimaraes; Arjan van Laarhoven; Maha R Farhat; Valerie A C M Koeken; Jornt J Mandemakers; Aldert Zomer; Sacha A F T van Hijum; Mihai G Netea; Megan Murray; Reinout van Crevel; Dick van Soolingen Journal: Am J Respir Crit Care Med Date: 2017-06-01 Impact factor: 21.405
Authors: Arjan van Laarhoven; Jornt J Mandemakers; Johanneke Kleinnijenhuis; Mimount Enaimi; Ekta Lachmandas; Leo A B Joosten; Tom H M Ottenhoff; Mihai G Netea; Dick van Soolingen; Reinout van Crevel Journal: Infect Immun Date: 2013-07-29 Impact factor: 3.441